Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2025-12-25 @ 9:52 PM
NCT ID: NCT01596751
Term: Aspartate aminotransferase increased
Organ System: Investigations
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE (4.0)
Notes: None
Study: NCT01596751
Study Brief: Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 1 1 5 View
EG001 2 1 4 View
EG002 0 0 3 View
EG003 3 2 6 View
EG004 7 3 4 View
EG005 3 2 6 View
EG006 20 7 17 View
EG007 24 10 22 View